semaglutide cardiac protection Evaluating the Cardiovascular Benefits of Innovator 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence ACC 2025: Oral Semaglutide Reduces

Simple Daily GLP-1 Nutrition Routine What might a simple supplement routine look like

[DOI] [PubMed] [Google Scholar] 86.Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME

Claudia von Boeselager (27:36) are decisions you need to make

Lipid profile improvements (TRIUMPH-4): Non-HDL cholesterol: Clinically meaningful reduction Triglycerides: Significant reduction hsCRP (inflammatory marker): Significant reduction HDL cholesterol: Not significantly improved (consistent with Phase 2 findings) The triglyceride reduction is particularly notable and likely related to glucagon receptor activation, which enhances fat oxidation